ZZ Bio Lands A Few Million Dollars In The Newest Round Of Financing
According to China Venture, in vitro diagnostic instrument consumables company ZZ Bio just received a few million dollars in the newest round of financing. This round of financing was led by Anlong Fund. The funds will be used to improve the production level and develop the next generation of products.
ZZ Bio was founded in 2016 in Shanghai, it is a company that focuses on the development, production and sales of in vitro diagnostic equipment supplies. ZZ Bio's team has management experts from leading medical device companies around the world, as well as scientists and technical experts in micro-nano processing, precision instruments, image algorithms and biological reagents.
ZZ Bio has successfully developed the first chip-type digital PCR instrument with independent intellectual property rights in China. The founder and CEO of ZZ Bio Feng Guo, claims that in the future, the company will use its own technology to gradually expand its product line to more IVD fields and achieve detection in fields such as molecules, cells and proteins.
About Anlong Fund
Anlong Fund is an investment firm that focuses on the life sciences and health care fields, and investing in high-quality startups at their early-stage.